[Macular edema after prior brachytherapy in a diabetic retinopathy patient (clinical case)].

The authors describe a case of radiation retinopathy after brachytherapy for uveal melanoma successfully treated with nepafenac 0.1%, a non-steroidal anti-inflammotory agent.

[Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].

Aim: To improve the approach to pathogenetic treatment of diabetic retinopathy (DR) through early diagnosis and a new method for predicting disease progression.

Material And Methods: The study enrolled 330 type 2 diabetes patients with DR (660 eyes), of whom women constituted 64.6%, men - 35.

[Extraocular muscles involvement in patients with thyroid-associated ophthalmopathy].

Aim: To study morphological features of extraocular muscles in patients with endocrine myopathy taking into account the duration of the disease.

Material And Methods: A total of 16 patients with thyroid eye disease were included in the study. After a routine ophthalmic examination, they all underwent extraocular muscle surgery and orbital decompression.

[Retinal vein occlusion management algorithm. Part 3. Neovascular complications].

Neovascular complications severity in central/branch retinal vein occlusion (RVO) correlates with the level of occlusion and the degree of retinal perfusion disturbance. Large areas of retinal non-perfusion (more than half of the total retinal area) are associated with the risk for posterior segment neovascularization as high as 33% and for neovascular glaucoma - 45%. Over the past 30 years there has been an evident declining tendency of neovascular complications rates in the natural course of RVO.

[Retinal vein occlusion management algorithm. Part 2. Macular edema].

Macular edema (ME) is the most common complication of both ischemic and nonischemic retinal vein occlusion (RVO). If the main trunk of the central retinal vein is involved, ME occurs in 100% of cases. According to the Central Vein Occlusion Study, in 65% of RVO and ME patients with baseline visual acuity (VA) of at least 0.

[Retinal vein occlusion management algorithm. Part 1. Classification, diagnosis, and acute-stage treatment].

Considering an upward global trend in cardiovascular disease rates, retinal vein occlusion (RVO) in particular, development of therapeutic guidelines is a pressing issue in ophthalmology. Risk factors for RVO include hypertension, atherosclerosis, diabetes mellitus, blood disorders, inflammatory disorders, and prescription drug use. Three stages of RVO have been identified.

[Custom-made artificial parts for improving functional and cosmetic results of ocular prosthetics].

Unlabelled: Aim - to justify the use of custom-made ocular prostheses aimed at better functional and cosmetic outcomes.

Material And Methods: Cosmetic outcomes in 520 patients operated for either anophthalmia (89.1%), or ocular subatrophy (6.